
Iovance Biotherapeutics to present at 2026 Jefferies Global Healthcare Conference in London
Iovance Biotherapeutics, a leader in tumor infiltrating lymphocyte (TIL) therapies for cancer, announced its senior leadership will present at the 2026 Jefferies Global Healthcare Conference in London on November 16. The company is known for its FDA-...

